If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Centre, a national research platform led by Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...

A serious health risk affecting your lungs and heart. Whether you're experiencing respiratory distress or seeking preventive ...

“Addressing the unmet needs of patients with severe, uncontrolled asthma and COPD, particularly through innovative ...

Long‐acting muscarinic antagonists (LAMAs) are a class of long-acting bronchodilators initially developed to treat COPD ... asthma treatment and begin developing your treatment team. Then, lean on ...